Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MEI Pharma | MEIP | Aug 30, 2024 | 3.10 | -4.91 |
Meihua International Medical Technologies | MHUA | Aug 30, 2024 | 0.91 | +3.95 |
MeiraGTx Holdings | MGTX | Aug 30, 2024 | 4.07 | -2.63 |
Meiwu Technology | WNW | Aug 30, 2024 | 0.82 | -0.23 |
Melar Acquisition I | MACIU | Aug 30, 2024 | 10.03 | 0.00 |
Melar Acquisition I | MACI | Aug 30, 2024 | 9.98 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Aug 30, 2024 | 5.07 | -0.39 |
MercadoLibre | MELI | Aug 30, 2024 | 2 061.66 | +2.28 |
Mercantile Bank | MBWM | Aug 30, 2024 | 45.98 | +0.88 |
Mercer International | MERC | Aug 30, 2024 | 6.00 | +0.67 |
Merchants Bancorp | MBIN | Aug 30, 2024 | 45.85 | +1.30 |
Merchants Bancorp B | MBINO | Aug 30, 2024 | 25.05 | +0.04 |
Merchants Bancorp C Pref | MBINN | Aug 30, 2024 | 21.16 | -2.67 |
Merchants Bancorp Pref D | MBINM | Aug 30, 2024 | 25.71 | +0.04 |
Merck & Co | MRK | Aug 30, 2024 | 118.45 | +0.84 |
Mercurity Fintech | MFH | Aug 30, 2024 | 1.50 | -0.99 |
Mercury General | MCY | Aug 30, 2024 | 66.23 | +0.11 |
Mercury Systems | MRCY | Aug 30, 2024 | 37.90 | +0.93 |
Mereo BioPharma ADR | MREO | Aug 30, 2024 | 4.69 | +2.40 |
Meridian | MRBK | Aug 30, 2024 | 11.65 | +0.34 |
MeridianLink | MLNK | Aug 30, 2024 | 22.83 | +0.66 |
Merit Medical Systems | MMSI | Aug 30, 2024 | 96.68 | +0.71 |
Meritage Homes | MTH | Aug 30, 2024 | 198.07 | +0.49 |
Merrill Lynch & Co. | IPB | Aug 30, 2024 | 27.18 | +3.54 |
Mersana Therapeutics | MRSN | Aug 30, 2024 | 1.58 | +3.95 |
Merus N.V | MRUS | Aug 30, 2024 | 50.99 | +1.01 |
Mesa Air Group | MESA | Aug 30, 2024 | 1.23 | -2.77 |
Mesa Laboratories | MLAB | Aug 30, 2024 | 133.69 | -0.38 |
Mesa Royalty Trust | MTR | Aug 30, 2024 | 6.34 | -2.31 |
Mesabi Royalty Trust | MSB | Aug 30, 2024 | 16.97 | -0.35 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.